gmi 2018.png
Pet Cancer Therapeutics Market to hit $359.4 Million by 2025: Global Market Insights, Inc.
March 15, 2019 03:04 ET | Global Market Insights, Inc
Sellbyville, Delaware, March 15, 2019 (GLOBE NEWSWIRE) -- Australian pet cancer therapeutics market is forecast to grow at over 12.6% CAGR in given timeframe. High growth is due to growing...
Achilles-Therapeutics-Logo-RGB-Small.png
Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma
February 13, 2019 07:00 ET | Achilles Therapeutics
   Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma Second CTA approval in 2019 – the first was for a NSCLC study Stevenage, UK  13 February...
Achilles-Therapeutics-Logo-RGB-Small.png
Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma
February 13, 2019 03:00 ET | Achilles Therapeutics
   Achilles Therapeutics receives CTA Approval for Phase I/II Study in Metastatic or Recurrent Melanoma Second CTA approval in 2019 – the first was for a NSCLC study Stevenage, UK  13 February...
aad.jpg
Dermatology Experts Present Latest Information at 2018 AAD Summer Meeting; American Academy of Dermatology
July 26, 2018 08:00 ET | American Academy of Dermatology
CHICAGO, July 26, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Summer Meeting will take place from July 26 to 29 at the Hyatt Regency Chicago. The meeting will feature the...
provectus_logo.jpg
PROVECTUS BIOPHARMACEUTICALS ANNOUNCES ACCEPTANCE OF PV-10 POSTER PRESENTATION AT ESMO 2018 CONGRESS
July 24, 2018 07:00 ET | Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE KNOXVILLE, TN, July 24, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that data from the Company’s ongoing clinical trial of PV-10 for the treatment of...
provectus_logo.jpg
PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR ACTIVE PHARMACEUTICAL INGREDIENT MANUFACTURE
June 19, 2018 09:00 ET | Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE KNOXVILLE, TN, June 19, 2018 (GLOBE NEWSWIRE) -- Provectus today announced that the Indian Patent Office (IPO) has granted the Company’s patent application for the synthetic...
aad.jpg
How to Use Stick and Spray Sunscreens; American Academy of Dermatology
June 12, 2018 14:00 ET | American Academy of Dermatology
ROSEMONT, Ill., June 12, 2018 (GLOBE NEWSWIRE) -- Sunscreen is a vital tool in the fight against skin cancer, including melanoma, the deadliest form. Research suggests that daily sunscreen use —...
aad.jpg
American Academy of Dermatology PSA Highlights Dangers of Tanning
May 22, 2018 10:30 ET | American Academy of Dermatology
ROSEMONT, Ill., May 22, 2018 (GLOBE NEWSWIRE) -- As Memorial Day signals the unofficial start of summer, many teen girls will be eager to get out of school and spend time outside — and some may want...
aad.jpg
Research Shows Increased Skin Cancer Risk Among U.S. Military Members
May 17, 2018 16:14 ET | American Academy of Dermatology
ROSEMONT, Ill., May 17, 2018 (GLOBE NEWSWIRE) -- When one considers the risks of military service, skin cancer may not be top of mind. According to research published in the Journal of the American...
provectus_logo.jpg
PROVECTUS BIOPHARMACEUTICALS ANNOUNCES CHANGES TO BOARD OF DIRECTORS
April 24, 2018 07:00 ET | Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE Ed Pershing, CPA elected new Board chair Jack Lacey, MD named new Board director; also appointed new strategic advisory board chair KNOXVILLE, TN, April 24, 2018 ...